Tarek Sahmoud - Aug 12, 2022 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Role
Chief Medical Officer
Signature
/s/ Alex Levit, Attorney-in-Fact
Stock symbol
CNTX
Transactions as of
Aug 12, 2022
Transactions value $
$0
Form type
4
Date filed
8/12/2022, 04:31 PM
Previous filing
Oct 19, 2021
Next filing
Aug 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNTX Stock Option (right to buy) Award $0 +25K $0.00 25K Aug 12, 2022 Common Stock 25K $1.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable over a two-year period. Fifty percent (50%) of the option vests and becomes exercisable on June 17, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining one year of the two-year period, subject to continued service with the Issuer.